efgartigimod alfa
SpainDrugs containing this active substance
-
It is used in adults to treat generalized myasthenia gravis (gMG), an autoimmune disease that causes muscle weakness, and chronic inflammatory demyelinating polyneuropathy (CIDP), which causes weakness or numbness in the arms and legs.
Form: solution for injection in a pre-filled syringe
Active substance Dosage efgartigimod alfa 1000 mg Manufacturer: Argenx B.V.
-
It is used to treat adults with generalized myasthenia gravis (gMG), a disease that causes muscle weakness, and also to treat chronic inflammatory demyelinating polyneuropathy (CIDP), which causes weakness or numbness in the arms and legs.
Form: solution for injection
Active substance Dosage efgartigimod alfa 1000 mg Manufacturer: Argenx B.V.
-
It is used in adults with generalized myasthenia gravis (gMG), an autoimmune disease that causes muscle weakness, extreme fatigue, difficulty swallowing, or shortness of breath, to help improve muscle contraction capacity.
Form: solution for infusion, concentrate
Active substance Dosage efgartigimod alfa 20 mg/ml Manufacturer: Argenx B.V.